期刊文献+

来氟米特联合肿瘤坏死因子拮抗剂治疗早期类风湿关节炎的疗效观察 被引量:3

下载PDF
导出
摘要 目的:观察来氟米特联合肿瘤坏死因子拮抗剂治疗早期类风湿关节炎的临床效果及安全性。方法:对56例早期类风湿关节炎患者联合应用来氟米特及肿瘤坏死因子拮抗剂进行治疗,观察治疗前后的各项指标,进行比较分析。结果:治疗后患者在关节肿胀数、关节压痛数、晨僵时间以及C-反应蛋白和血沉方面均有明显改善,差异具有统计学意义(P<0.05),且不良反应轻微。结论:来氟米特联合肿瘤坏死因子拮抗剂是治疗早期类风湿关节炎的一种有效方法。
出处 《风湿病与关节炎》 2012年第2期49-50,共2页 Rheumatism and Arthritis
  • 相关文献

参考文献6

  • 1类风湿关节炎诊断及治疗指南[J].中华风湿病学杂志,2010,14(4):265-270. 被引量:1297
  • 2Arnett FC,Edworthy SM,Bloch DA. The American Rheumatism Association 1987 revisedcriteria for the classification of rheumatoid arthritis[J].Arthritis and Rheumatism,1988,(03):315-324.
  • 3Flandry F,Hughston JC,McCann SB. Diagnostic features of diffuse pigmented villonodular synovitis of the knee[J].Clinical Orthopaedics and Related Research,1994,(298):212-220.
  • 4Hardaker WT,Whipple TC,Bassett FH. Diagnosis and treatment of the plica syndrome of the knee[J].Journal of Bone and Joint Surgery-American Volume,1980,(02):221-225.
  • 5Paul C,Solignac M. Psoriasis and psoriatic rheumatism:effectiveness of etanercept for cutaneous and joint lesion[J].Annales de Dermatologie et de Vénéréologie,2010,(4Suppl):13-15.
  • 6Blom M,Kievit W,Kuper HH. Frequency and effectiveness of dose increase of adalimumab,etanercept,and infliximab in daily clinical practice[J].Arthritis Care Res (Hoboken),2010,(09):1335-1341.

共引文献1296

同被引文献24

  • 1陈颖娟,高洁生,吴轰,李芬,田静,谢希.不同DMARDs联合用药治疗类风湿关节炎疗效与安全性的研究[J].中国现代医学杂志,2005,15(4):576-581. 被引量:18
  • 2范秀珍,王华杰.三组类风湿关节炎治疗方案的药物经济学分析[J].药物流行病学杂志,2005,14(1):39-41. 被引量:5
  • 3Geiler J,Buch M,Mcdermott MF. Anti-TNF treatment in rheumatoid arthritis [ J 1 . Curr Pharm Des,2011,17 ( 29 ) :3141-3154.
  • 4Weinblatt ME,Reda D,Henderson W,et al Sulfasalazine treatment for rheumatoid arthritis a metaanalysis of 15 randomized trials [ J .J Rheu- matol,1999,26 (10) :2123-2130.
  • 5Emery P a cohort ,Cannon G,Holden W,et of 40,000 rheumatoid aI.Results from arthritis ( RA ) patients: adverse event ( LEF ) ,methotrexate ( AE ) profiles of leflunomide ( MTX ) and other disease- modifying antirheumatic drugs Ann Rheum Dis,2002,61 ( 1 ) :42.
  • 6Aletaha D, Smolenmohn JS,Efectiveness profiles and dose dependent retention of traditional modifying antirheumatic drugs for rheumatoid An observation study I J 1 J Rheumatol,2002, 1631-1638 disease arthritis. 29( 8 ):.
  • 7周凌,包军,许臻,徐沪济.抗风湿病药物对于类风湿性关节炎血脂的影响[J].临床内科杂志,2007,24(11):782-783. 被引量:6
  • 8Ogata A, Tanaka T. Toeilizumab for the treatment of rheumatoid arthri- tis and other systemicautoimmune diseases:current perspectives and fu- ture directions[ J]. Int J Rheumatol, 2012, (2012) :946048.
  • 9Li H, Wan A. Apoptosis of rheumatoid arthritis flbroblast - like syno- viocytes: possiblemles of nitric oxide and the thioredoxinl [ J]. Mediators Inflamm, 2013, (2013) :953462.
  • 10Wada TT, Araki Y, Sato K, etal. Aberrant histone acetylation contrib- utes to elevated interleukin -6 production in rheumatoid arthritis synovi- al fibroblasts[ J]. Biochem Biophys Res Commun, 2014,444(4) :682 - 686.

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部